Most Read News

The Company has secured orders worth Rs50,359cr during the quarter ended December 31, 2021, registering a decline of 31% yoy.

The lender recorded a net interest income of Rs3,794cr in Q3FY22, growing by 11% YoY and 4% QoQ. Net Interest Margin for Q3 FY22 stood at 4.10% against 4.12% for Q3 FY21 and 4.07% for Q2 FY22.

Company could post revenue growth of 8% on a YoY basis, and flat sequentially.

IREDA is looking forward to extending its consulting services to other PSUs and private organisations for the overall growth of the RE sector.

L&T: The engineering and construction majors consolidated net profit fell 16.70% to Rs 2,054.74 crore on 11.14% increase in net sales to Rs 39,562.92 crore in Q3 December 2021 over Q3 December 2020. Vedanta: On a consolidated basis, the diversified natural resources firms net profit rose 26% to Rs 4,164 crore on 50% increase in net sales to Rs 33,697 crore in Q3 December 2021 […]

On a 24-month basis, for nine months ended 31 st December 2021, the Consolidated Sales and Net Profit grew 21% and 11% respectively.

Japan retail sales was up 1.4 percent on year in December, the Ministry of Economy, Trade and Industry said on Monday, coming in at 14.656 trillion yen, and was down from 1.9 percent in November. On a seasonally adjusted monthly basis, retail sales were down 1.0 percent after rising an upwardly revised 1.3 percent in November (originally 1.2 percent). For the fourth quarter of 2021, […]

US personal income rose by 0.3 percent in December after climbing by an upwardly revised 0.5 percent in November, a report released by the Commerce Department on Friday showed. Disposable personal income, or personal income less personal current taxes, also edged up by 0.2 percent in December after rising by 0.4 percent in November. When adjusted for inflation, however, disposable personal income actually dipped by […]

The wholly-owned foreign subsidiary of Granules India, Granules Pharmaceuticals, Inc. (GPI) in Chantilly, Virginia (US) had undergone a pre-approval inspection by the US Food and Drug Administration (USFDA) from 24 to 28 January 2022.

The Indian rupee is likely stay range bound with all eyes on the upcoming budget session that would be the key event that the market would be looking for. However, geopolitical tensions, elevated crude oil prices and hawkish US Fed stance driving greenback higher could weigh on the local unit. On Friday, rupee snapped its three-day losing streak to close 5 paise higher at 75.04 […]